Compare AZN & MS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AZN | MS |
|---|---|---|
| Founded | 1992 | 1924 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 286.0B | 342.1B |
| IPO Year | 1995 | 2025 |
| Metric | AZN | MS |
|---|---|---|
| Price | $183.94 | $184.80 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 26 |
| Target Price | $208.08 | ★ $211.50 |
| AVG Volume (30 Days) | 2.8M | ★ 4.5M |
| Earning Date | 10-30-2026 | 10-14-2026 |
| Dividend Yield | 1.75% | ★ 2.41% |
| EPS Growth | N/A | ★ 28.43 |
| EPS | N/A | ★ 9.93 |
| Revenue | N/A | ★ $34,275,000,000.00 |
| Revenue This Year | $7.90 | $17.31 |
| Revenue Next Year | $6.38 | $5.06 |
| P/E Ratio | $31.91 | ★ $19.15 |
| Revenue Growth | N/A | ★ 5.73 |
| 52 Week Low | $88.41 | $152.80 |
| 52 Week High | $212.71 | $232.25 |
| Indicator | AZN | MS |
|---|---|---|
| Relative Strength Index (RSI) | 61.27 | 44.96 |
| Support Level | $181.04 | $182.03 |
| Resistance Level | $193.52 | $194.95 |
| Average True Range (ATR) | 3.62 | 5.07 |
| MACD | -0.24 | 0.70 |
| Stochastic Oscillator | 66.48 | 25.03 |
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Morgan Stanley is a massive global financial services firm, with offices in 42 countries and more than 82,000 employees as of year-end 2025. The firm cut its teeth in investment banking and institutional trading, where it maintains a strong presence today, but generates the lion share of its income from wealth and asset management franchises, where it boasted $9.3 trillion in client assets at the end of 2025. After reincorporation as a bank holding company in the wake of the global financial crisis, Morgan Stanley also boasts a top 10 banking franchise by deposits, with more than $400 billion in customer deposits, predominately attributable to cash sweeps from its wealth management and brokerage businesses.